Clinical Trial Update: Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension [NA]

View source ↗

Summary

A clinical trial update notes that a study evaluating phosphodiesterase type 5 inhibitors for Group 2 pulmonary hypertension is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Phosphodiesterase type 5 inhibitors

Snippet

Sponsor: Beni-Suef University | Conditions: Group 2 Pulmonary Hypertension | NA | Status: ACTIVE_NOT_RECRUITING